How Has the Osteoarthritis Therapeutics Market Evolved Historically and What is its Current Size?
The osteoarthritis therapeutics market has seen considerable growth due to a variety of factors.
• In the past few years, the osteoarthritis therapeutics market has seen significant growth. The market size is projected to increase from $8.17 billion in 2024 to $8.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%.
Factors contributing to this growth include the aging population, progress in drug delivery technology, an increase in awareness and diagnoses, the introduction of innovative treatments, and rising obesity rates.
What Is The Projected Growth Of The Osteoarthritis Therapeutics Template Market?
The osteoarthritis therapeutics market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of osteoarthritis therapeutics is predicted to experience remarkable growth in the upcoming years. It is projected to escalate to $12.22 billion by 2029, with an 8.3% compound annual growth rate (CAGR). Factors contributing to this growth during the projected period include an increase in obesity rates, advancements in treatment methods, rising awareness and diagnosis rates, progress in the creation of disease-modifying osteoarthritis drugs (DMOADs), and both government and private sector research funding. Future trends to watch include a growing interest in personalized medicine, the advent of regenerative therapies, the broadening of pain management alternatives, governmental and regulatory backing, and amplified demand from developing markets.
What Are The Key Drivers Fueling Growth In The Osteoarthritis Therapeutics Market?
The escalation in sports-related injuries is anticipated to fuel the expansion of the osteoarthritis therapeutics market. Such injuries, which may be minor or serious, occur during sports or athletic events and can impact varying parts of the body. The prevalence of sports injuries is increasing mainly because of heightened participation in sports and the escalating aggressiveness and competitive nature of these activities. Athletes battling joint degradation employ osteoarthritis therapeutics to manage pain and inflammation, and enhance joint functionality due to sports injuries. For example, in 2022, the National Safety Council, a nonprofit organization based in the US that advocates for health and safety, stated that sports and recreational injuries reported in 2022 had risen by 12%. Therefore, the surge in sports injuries is spurring the growth of the osteoarthritis therapeutics market.
What Are The Principal Market Segments In The Global Osteoarthritis Therapeutics Industry?
The osteoarthritis therapeuticsmarket covered in this report is segmented –
1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses
Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy
Pre-Book The Osteoarthritis Therapeutics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Osteoarthritis Therapeutics Market?
Leading organizations in the osteoarthritis therapeutic market are concentrating their efforts on creating breakthrough solutions, particularly in the realm of tissue regeneration for osteoarthritis. This refers to the restoration or substitution of damaged cartilage and joint tissues to reinstate regular function and ease discomfort. In May 2023, for example, the Advanced Research Projects Agency for Health (ARPA-H), a government body from the United States, initiated the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program. The NITRO initiative, under the responsibility of ARPA-H, aims to develop revolutionary injectable treatments to stimulate cartilage repair, by exploiting biological pathways reminiscent of those employed during embryonic growth. The program is marked by unique aspects such as cooperative multimodal strategies among research units and sophisticated testing methods like "joint-on-a-chip" platforms, which emulate joint conditions. The primary objective is to devise restorative solutions that tackle the root causes of osteoarthritis.
Who Are the Key Players In The Osteoarthritis Therapeutics Market?
Major companies operating in the osteoarthritis therapeutics market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• GlaxoSmithKline plc
• Medtronic plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Daiichi Sankyo Company Limited
• Zimmer Biomet Holdings Inc.
• Horizon Therapeutics plc
• Taisho Pharmaceutical Co. Ltd.
• Ferring Pharmaceuticals
• Galapagos NV
• Bioventus LLC
• Flexion Therapeutics Inc.
• Anika Therapeutics Inc.
• Seikagaku Corporation
• Samumed LLC
• Orthogen AG
• Kolon Life Science Inc.
What Are The Regional Insights Into The Osteoarthritis Therapeutics Market?
North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
